Big/Suspected Movers FAQ/User Guide
What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that...
top of page
BPIQ Blog
Aug 28, 20231 min read
Quarterly Big Mover Biotech Stocks To Watch
Our free Big-Mover Report : Listing of 10 of the biggest clinical readouts this quarter Use this info: To update your holdings before a...
Aug 17, 20231 min read
Q2 2023 Product Revenue Analyses
We have gone through the Q2 2023 financial reports to analysis each companies product revenue to see: Q2 '23 revenue Q2 '22 revenue Q2...
Aug 15, 20233 min read
BPIQ Q2 2023 Biotech Hedge Fund (13F) Analysis
Last updated 8/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...
Aug 7, 20231 min read
SYFOVRE (APLS) vs. IZERVAY (Astellas)
Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...
Aug 7, 20231 min read
BIIB & SAGE: Zuranolone
Big PDUFA from a big collaboration: BIIB & SAGE PDUFA - 8/5/23 - Zuranolone in MDD & PPD Collaboration since 2020… BIIB invested $1.5B in...
Jul 31, 20231 min read
Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...
Jul 24, 20231 min read
How to make $$$ investing in biopharma
Consistent with top 36 biopharma hedge funds • Each held 22-125 companies @ end Q1 ⇒ Stonepine (22 companies) ⇒ EcoR1 (58) ⇒ RA Capital...
Jul 17, 20231 min read
Scpharmaceuticals (SCPH)... Is Summer Stock Dip a Buying Opportunity?
Overview: • Under the radar companies • Huge upside • Difficult FDA approval behind them ⇒ Typical for drug device combo ⇒ 2 CRLs • But...
Jul 17, 20231 min read
PRTA & BMS Collaboration
PRTA tech validated by big BMS collaboration • BMS is part owner of PRTA BMS & PRTA collaboration highlights: 3/20/18 CELG & PRTA enter...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page